
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
- COVID-19
- New Therapies and Current Patient Management of Lymphomas
- Update on Patient Care Treatment Strategies in Leukemia
- Controversies and Update for Patient Care in Multiple Myeloma
UPenn ASH Highlights on PI3Ki & BTKi for R/R MZL: How Effective Are Parsaclisib & Zanubrutinib?
81 views
March 2, 2021
Comments 0
Login to view comments.
Click here to Login
New Therapies and Current Patient Management of Lymphomas